Developer docs
API playgroundTry for free, no card

Search company profiles

Korsch

Full company profile

uuid0008umc

Namestring
Korsch
Legal namestring
Korsch Aktiengesellschaft
Websiteurl
korsch.com
Company typeenum
Private
Founded yearint
1900
Descriptiontext

Korsch Aktiengesellschaft (Korsch AG) is a Berlin-based German engineering company that designs, develops, and manufactures rotary tablet compression machinery, founded around 1900 and operating for more than 100 years. The company serves pharmaceutical manufacturers as its primary customer segment, with additional verticals in food and confectionery, chemical, and technical applications (batteries, catalysts, airbag components, magnets, sintered metals). Its product portfolio spans the full product lifecycle from research-scale presses (XP 1, EK 2, STYL'ONE Evo family) through scale-up and high-speed production systems (X3, XM12, XL 400, XT 300), with output capacities reaching 324,000 tablets per hour on flagship models.

Korsch's technology platform centers on proprietary systems including the PharmaControl press force control system for real-time weight monitoring, DryCon and WipCon containment technologies meeting OEB 4-5 standards for highly potent active pharmaceutical ingredients (HPAPIs), and Industry 4.0-compatible Siemens-based control architectures. The company operates the Berlin Innovation Center for formulation development, process optimization, and scale-up support, and complements its equipment with strategic partnerships covering compaction simulation (MEDELPHARM) and granulation/coating/continuous manufacturing (L.B. BOHLE).

The business model is built on direct hardware sales of capital equipment, distributed through wholly-owned subsidiaries in Germany, the United States, India, South Korea, and Indonesia, supplemented by a global network of regional distributors and agents. Pricing is quote-based and not publicly disclosed. The company is privately held with no disclosed external venture or private equity investment, serves a 10,000+ installed base of customers globally, and emphasizes enterprise field sales with dedicated regional contacts and full lifecycle support from R&D through to 24/7 production.

Short descriptiontext

Korsch AG is a German manufacturer of pharmaceutical tablet compression machinery, offering research-scale to high-speed production presses with proprietary containment and process control systems for pharmaceutical, food, chemical, and technical industries worldwide.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersBerlin, Germany
HQ citystring
Berlin
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
tablet compression machines, pharmaceutical tablet presses, rotary tablet presses, high containment tableting, R&D tablet press equipment
Industry2 codes
PRIMARYIMAHAOAF
Filling & Dosing Machines (Liquid/Powder/Solid)
SECONDARYIMALAOAB
Filling & Dosing Equipment (Liquid, Powder, Aseptic)
Product category
Pharmaceutical Tablet Press Equipment
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Tablet Press Equipment Sales
TypeHardware Sales
Description

Korsch generates revenue through the sale of tablet press machinery and equipment, including research presses, scale-up systems, and high-speed production presses. The company also offers customization options, containment solutions, and related peripheral equipment.

korsch.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Technology or R&D, Personnel, Operations, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Korsch designs, develops, and manufactures rotary tablet press machinery used to compress powders into tablets for the pharmaceutical, food and confectionery, chemical, and technical industries. The product line spans research-scale presses (XP 1, EK 2, STYL'ONE Evo family) to high-speed production presses (X3, XM12, XL 400, XT 300), complemented by proprietary containment solutions (WipCon, DryCon) and the PharmaControl press force control system, with a Berlin-based Innovation Center supporting formulation development, process optimization, and scale-up services.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Up to 324,000 tablets per hour output with XT 300 press
+1 more record
Product overview1 text field

Korsch is a tablet compression specialist offering a comprehensive portfolio of pharmaceutical tablet presses spanning from R&D to full-scale production. The product line includes research presses (XP 1, EK 2, STYL'ONE Evo family), production presses (X3, XM12, XL 400, XT 300), and specialized containment solutions (WipCon, DryCon). Korsch provides the entire tableting ecosystem including the PharmaControl press force control system and Innovation Center services for formulation development, process optimization, and scale-up support. The company serves pharmaceutical, food & confectionery, chemical, and technical industries with over 10,000 installed tablet presses worldwide.

Product and service14 records
1Korsch XL 400
CategoryProduction Tablet Press
Description

High-performance tablet press designed for full-scale 24/7 production environments in pharmaceutical, food, chemical, and technical applications.

2Korsch XP 1
CategoryResearch Tablet Press
Description

Small-scale research tablet press used for feasibility studies with very small material quantities, evaluating flow, compressibility, and content uniformity of formulations.

3EK 2
CategoryResearch Tablet Press
Description

Tablet press designed for very large tablet formats, used for feasibility studies and formulation development.

4Korsch X3
CategoryHigh-Containment Production Tablet Press
Description

High-containment tablet press featuring Band 5 containment capabilities for safe manufacture of highly potent active pharmaceutical ingredients (HPAPIs) at clinical and commercial scales, supporting complex oral solid dosage therapies.

5Korsch XM12
CategoryProduction Tablet Press
Description

Production tablet press used by pharmaceutical manufacturers for technological advancement in tablet production capabilities.

6Korsch XT 300 Tablet Press
CategoryHigh-Speed Production Tablet Press
Description

Compact single-sided high-speed rotary tablet press that serves as an entry platform into Korsch production technology, achieving outputs up to 324,000 tablets per hour with up to 80 kN main compression force.

7STYL'ONE Evo
CategoryR&D Tablet Press
Description

Research and development tablet press platform used for compaction studies and formulation optimization, available in multiple configurations and capable of meeting OEB 5 containment requirements when configured with WipCon technology.

8STYL'ONE Nano WipCon
CategoryHigh-Containment R&D Tablet Press
Description

Compact R&D tablet press with WipCon containment technology meeting OEB 5 requirements for handling highly potent compounds.

9STYL'ONE Evo WipCon
CategoryHigh-Containment R&D Tablet Press
Description

R&D tablet press with WipCon containment system meeting OEB 5 requirements, featuring integrated weighing and measuring capabilities inside the isolator.

10STYL'ONE Evo DryCon
CategoryHigh-Containment R&D Tablet Press
Description

R&D tablet press with DryCon single- and multilayer compaction technology, featuring glove ports and optional isolator configuration for OEB 4 containment.

11WipCon Containment System
CategoryContainment Technology
Description

Proprietary containment solution meeting OEB 5 requirements using innovative misting technology that binds dust particles, providing operator protection and reducing cleaning effort for tablet production with highly potent active ingredients.

12DryCon Containment System
CategoryContainment Technology
Description

Proprietary economical containment solution using innovative misting technology for tablet production up to OEB level 4, featuring a Restricted Access Barrier System (RABS) with negative pressure control, glove ports, and Rapid Transfer Port (RTP).

13PharmaControl Press Force Control System
CategoryPress Force Control Technology
Description

Proprietary press force control system ensuring precise tablet weight control through continuous monitoring of individual compression forces with real-time display of average and individual forces.

14Korsch Innovation Center Services
CategoryTechnical Services
Description

Technical service facility in Berlin equipped with the latest Korsch tablet presses, peripherals, in-process test equipment, analytical equipment, and powder processing technology, supporting formulation development, process optimization, scale-up, and feasibility studies for customers.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic partnership integrating MEDELPHARM compaction simulator technology into Korsch's equipment portfolio. This partnership adds important development capabilities permitting streamlined material characterization and predictive studies on high-speed performance with minimal material quantities. Korsch Innovation Center works closely with MEDELPHARM's Science Lab in Lyon, France.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic partnership with L.B. BOHLE adds expertise around upstream and downstream processes including granulation, roller compacting, tablet coating, and continuous manufacturing systems. Korsch customers benefit from access to the LB BOHLE Technology Center in Ennigerloh, Germany.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Joint research projects with technical universities supporting product development and innovation in tablet compression technology.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

German-headquartered specialist in tablet press technology serving the same pharmaceutical and related compression customers as Korsch. It is the closest direct competitor, competing head-to-head on rotary presses, containment, and high-speed production platforms.

2Thomas Engineering
TypeDirect peer
Description

US-based manufacturer of tablet presses (including the PrecisePress and Elite lines) and related tablet tooling. Thomas Engineering is a direct peer competing primarily in mid-volume and specialty tablet compression, with overlap on containment applications.

TypeBroad incumbent
Description

Formerly Bosch Packaging Technology, Syntegon provides processing and packaging equipment for pharmaceuticals, including tablet presses and containment systems. It is a broad incumbent with similar customer overlap to Korsch in oral solid dose manufacturing.

TypeDirect peer
Description

German manufacturer of pharmaceutical processing and packaging machinery, including filling, closing, and containment systems for injectables and solid dose. While more focused on filling, it competes with Korsch on containment solutions for HPAPIs and complex oral solid dose formats.

TypeDirect peer
Description

Pharmaceutical processing and packaging equipment supplier offering tablet presses, granulation, and coating systems. Romaco is a direct peer to Korsch in mid- to high-volume tablet production, particularly in European markets.

TypeBroad incumbent
Description

Part of the diversified GEA Group, offering tablet presses alongside granulation, containment and continuous manufacturing systems for pharma. It competes with Korsch on integrated tableting lines and leverages a much larger balance sheet and global service network.

TypeDirect peer
Description

German manufacturer of granulation, drying, coating, and continuous manufacturing equipment, and Korsch's strategic partner for end-to-end tableting lines. L.B. Bohle is both a complement and a competitor on the integrated solutions Korsch pitches to pharma customers.

TypeEmerging player
Description

North American arm of Chinese pharmaceutical equipment group Truking, offering tablet presses and solid dose processing equipment. It competes with Korsch on price-sensitive and emerging-market deals, particularly for generic manufacturers in Asia and the Americas.

TypeBroad incumbent
Description

Italian leader in processing and packaging machinery for the pharma and food industries, with a broad tableting and containment portfolio. IMA competes with Korsch especially on integrated solutions for high-containment oral solid dose manufacturing.

10Glatt Group
TypeDirect peer
Description

Family-owned German specialist in pharmaceutical process technology, including fluid bed granulation, coating, and tablet production equipment. Glatt competes with Korsch in upstream/downstream tableting and integrated continuous manufacturing solutions.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles15 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries4 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Korsch

Pharmaceutical Tablet Press Equipmentkorsch.com

Korsch AG is a German manufacturer of pharmaceutical tablet compression machinery, offering research-scale to high-speed production presses with proprietary containment and process control systems for pharmaceutical, food, chemical, and technical industries worldwide.

What Korsch does

Korsch Aktiengesellschaft (Korsch AG) is a Berlin-based German engineering company that designs, develops, and manufactures rotary tablet compression machinery, founded around 1900 and operating for more than 100 years. The company serves pharmaceutical manufacturers as its primary customer segment, with additional verticals in food and confectionery, chemical, and technical applications (batteries, catalysts, airbag components, magnets, sintered metals). Its product portfolio spans the full product lifecycle from research-scale presses (XP 1, EK 2, STYL'ONE Evo family) through scale-up and high-speed production systems (X3, XM12, XL 400, XT 300), with output capacities reaching 324,000 tablets per hour on flagship models.

Korsch's technology platform centers on proprietary systems including the PharmaControl press force control system for real-time weight monitoring, DryCon and WipCon containment technologies meeting OEB 4-5 standards for highly potent active pharmaceutical ingredients (HPAPIs), and Industry 4.0-compatible Siemens-based control architectures. The company operates the Berlin Innovation Center for formulation development, process optimization, and scale-up support, and complements its equipment with strategic partnerships covering compaction simulation (MEDELPHARM) and granulation/coating/continuous manufacturing (L.B. BOHLE).

The business model is built on direct hardware sales of capital equipment, distributed through wholly-owned subsidiaries in Germany, the United States, India, South Korea, and Indonesia, supplemented by a global network of regional distributors and agents. Pricing is quote-based and not publicly disclosed. The company is privately held with no disclosed external venture or private equity investment, serves a 10,000+ installed base of customers globally, and emphasizes enterprise field sales with dedicated regional contacts and full lifecycle support from R&D through to 24/7 production.

Korsch firmographics

Firmographics
Name
Korsch
Legal name
Korsch Aktiengesellschaft
Website
https://korsch.com
Company type
Private
Founded year
1900
Operating status
Operating
Headcount range
101–250 employees
Short description
Korsch AG is a German manufacturer of pharmaceutical tablet compression machinery, offering research-scale to high-speed production presses with proprietary containment and process control systems for pharmaceutical, food, chemical, and technical industries worldwide.
Ownership category
akta.pro rank

Korsch industry classification

Industry
Product category
Pharmaceutical Tablet Press Equipment
akta.pro industry
PRIMARYIMAHAOAF
Filling & Dosing Machines (Liquid/Powder/Solid)
SECONDARYIMALAOAB
Filling & Dosing Equipment (Liquid, Powder, Aseptic)

Keywords

  • Tablet compression machines
  • Pharmaceutical tablet presses
  • Rotary tablet presses
  • High containment tableting
  • R&D tablet press equipment

Where Korsch is headquartered

Location

Headquarters

HQ city
Berlin
HQ country
Germany
HQ region
Europe

Offices5 records

Markets served

Korsch business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Personnel, Operations, Infrastructure, Marketing or Sales

Revenue model

  1. Tablet Press Equipment Sales: Korsch generates revenue through the sale of tablet press machinery and equipment, including research presses, scale-up systems, and high-speed production presses. The company also offers customization options, containment solutions, and related peripheral equipment.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Korsch product offering

Product offering

Core offering

Korsch designs, develops, and manufactures rotary tablet press machinery used to compress powders into tablets for the pharmaceutical, food and confectionery, chemical, and technical industries. The product line spans research-scale presses (XP 1, EK 2, STYL'ONE Evo family) to high-speed production presses (X3, XM12, XL 400, XT 300), complemented by proprietary containment solutions (WipCon, DryCon) and the PharmaControl press force control system, with a Berlin-based Innovation Center supporting formulation development, process optimization, and scale-up services.

Product overview

Korsch is a tablet compression specialist offering a comprehensive portfolio of pharmaceutical tablet presses spanning from R&D to full-scale production. The product line includes research presses (XP 1, EK 2, STYL'ONE Evo family), production presses (X3, XM12, XL 400, XT 300), and specialized containment solutions (WipCon, DryCon). Korsch provides the entire tableting ecosystem including the PharmaControl press force control system and Innovation Center services for formulation development, process optimization, and scale-up support. The company serves pharmaceutical, food & confectionery, chemical, and technical industries with over 10,000 installed tablet presses worldwide.

Differentiator

Problem solved

Functional benefit

Products and services

  • Korsch XL 400 High-performance tablet press designed for full-scale 24/7 production environments in pharmaceutical, food, chemical, and technical applications.
  • Korsch XP 1 Small-scale research tablet press used for feasibility studies with very small material quantities, evaluating flow, compressibility, and content uniformity of formulations.
  • EK 2 Tablet press designed for very large tablet formats, used for feasibility studies and formulation development.
  • Korsch X3 High-containment tablet press featuring Band 5 containment capabilities for safe manufacture of highly potent active pharmaceutical ingredients (HPAPIs) at clinical and commercial scales, supporting complex oral solid dosage therapies.
  • Korsch XM12 Production tablet press used by pharmaceutical manufacturers for technological advancement in tablet production capabilities.
  • Korsch XT 300 Tablet Press Compact single-sided high-speed rotary tablet press that serves as an entry platform into Korsch production technology, achieving outputs up to 324,000 tablets per hour with up to 80 kN main compression force.
  • STYL'ONE Evo Research and development tablet press platform used for compaction studies and formulation optimization, available in multiple configurations and capable of meeting OEB 5 containment requirements when configured with WipCon technology.
  • STYL'ONE Nano WipCon Compact R&D tablet press with WipCon containment technology meeting OEB 5 requirements for handling highly potent compounds.
  • STYL'ONE Evo WipCon R&D tablet press with WipCon containment system meeting OEB 5 requirements, featuring integrated weighing and measuring capabilities inside the isolator.
  • STYL'ONE Evo DryCon R&D tablet press with DryCon single- and multilayer compaction technology, featuring glove ports and optional isolator configuration for OEB 4 containment.
  • WipCon Containment System Proprietary containment solution meeting OEB 5 requirements using innovative misting technology that binds dust particles, providing operator protection and reducing cleaning effort for tablet production with highly potent active ingredients.
  • DryCon Containment System Proprietary economical containment solution using innovative misting technology for tablet production up to OEB level 4, featuring a Restricted Access Barrier System (RABS) with negative pressure control, glove ports, and Rapid Transfer Port (RTP).
  • PharmaControl Press Force Control System Proprietary press force control system ensuring precise tablet weight control through continuous monitoring of individual compression forces with real-time display of average and individual forces.
  • Korsch Innovation Center Services Technical service facility in Berlin equipped with the latest Korsch tablet presses, peripherals, in-process test equipment, analytical equipment, and powder processing technology, supporting formulation development, process optimization, scale-up, and feasibility studies for customers.

Quantifiable outcome

  • Up to 324,000 tablets per hour output with XT 300 press
  • +1 more outcomes

Companies that use Korsch

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles4 records

Korsch technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Korsch partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • MEDELPHARMcoreStrategic or Co-development PartnerStrategic partnership integrating MEDELPHARM compaction simulator technology into Korsch's equipment portfolio. This partnership adds important development capabilities permitting streamlined material characterization and predictive studies on high-speed performance with minimal material quantities. Korsch Innovation Center works closely with MEDELPHARM's Science Lab in Lyon, France.
  • L.B. BOHLEcoreStrategic or Co-development PartnerStrategic partnership with L.B. BOHLE adds expertise around upstream and downstream processes including granulation, roller compacting, tablet coating, and continuous manufacturing systems. Korsch customers benefit from access to the LB BOHLE Technology Center in Ennigerloh, Germany.
  • Technical UniversitiesminorStrategic or Co-development PartnerJoint research projects with technical universities supporting product development and innovation in tablet compression technology.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Korsch competitors and assessment

Company assessment

Direct peers

  • Fette Compacting: German-headquartered specialist in tablet press technology serving the same pharmaceutical and related compression customers as Korsch. It is the closest direct competitor, competing head-to-head on rotary presses, containment, and high-speed production platforms.
  • Thomas Engineering: US-based manufacturer of tablet presses (including the PrecisePress and Elite lines) and related tablet tooling. Thomas Engineering is a direct peer competing primarily in mid-volume and specialty tablet compression, with overlap on containment applications.
  • Bausch + Ströbel: German manufacturer of pharmaceutical processing and packaging machinery, including filling, closing, and containment systems for injectables and solid dose. While more focused on filling, it competes with Korsch on containment solutions for HPAPIs and complex oral solid dose formats.
  • Romaco Group: Pharmaceutical processing and packaging equipment supplier offering tablet presses, granulation, and coating systems. Romaco is a direct peer to Korsch in mid- to high-volume tablet production, particularly in European markets.
  • L.B. Bohle: German manufacturer of granulation, drying, coating, and continuous manufacturing equipment, and Korsch's strategic partner for end-to-end tableting lines. L.B. Bohle is both a complement and a competitor on the integrated solutions Korsch pitches to pharma customers.
  • Glatt Group: Family-owned German specialist in pharmaceutical process technology, including fluid bed granulation, coating, and tablet production equipment. Glatt competes with Korsch in upstream/downstream tableting and integrated continuous manufacturing solutions.

Broad incumbents

  • Syntegon Technology: Formerly Bosch Packaging Technology, Syntegon provides processing and packaging equipment for pharmaceuticals, including tablet presses and containment systems. It is a broad incumbent with similar customer overlap to Korsch in oral solid dose manufacturing.
  • GEA Pharma & Healthcare: Part of the diversified GEA Group, offering tablet presses alongside granulation, containment and continuous manufacturing systems for pharma. It competes with Korsch on integrated tableting lines and leverages a much larger balance sheet and global service network.
  • IMA Group: Italian leader in processing and packaging machinery for the pharma and food industries, with a broad tableting and containment portfolio. IMA competes with Korsch especially on integrated solutions for high-containment oral solid dose manufacturing.

Emerging players

  • MG America (Truking): North American arm of Chinese pharmaceutical equipment group Truking, offering tablet presses and solid dose processing equipment. It competes with Korsch on price-sensitive and emerging-market deals, particularly for generic manufacturers in Asia and the Americas.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Korsch social profiles

Digital presence

Korsch financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Korsch leadership team

Management profile

Number of profiles

Profiles15 records

Korsch subsidiaries and ownership

Company hierarchy

Subsidiaries4 records

Korsch funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Korsch M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Korsch

What does Korsch do?

Korsch designs, develops, and manufactures rotary tablet press machinery used to compress powders into tablets for the pharmaceutical, food and confectionery, chemical, and technical industries. The product line spans research-scale presses (XP 1, EK 2, STYL'ONE Evo family) to high-speed production presses (X3, XM12, XL 400, XT 300), complemented by proprietary containment solutions (WipCon, DryCon) and the PharmaControl press force control system, with a Berlin-based Innovation Center supporting formulation development, process optimization, and scale-up services.

Is Korsch a public or private company?

Korsch is a private company. It is classified as family owned and is currently operating.

When was Korsch founded?

Korsch was founded in 1900. It employs 101 to 250 people.

Where is Korsch based?

Korsch is headquartered in Berlin, Germany, in the Europe region.

How does Korsch make money?

One revenue line is on record: tablet Press Equipment Sales.

Who are Korsch's main competitors?

Direct peers on record are Fette Compacting, Thomas Engineering, Bausch + Ströbel, Romaco Group, L.B. Bohle and Glatt Group. Broad incumbents are Syntegon Technology, GEA Pharma & Healthcare and IMA Group. MG America (Truking) is listed as an emerging player.

Does Korsch have an API?

No public API is recorded for Korsch.

What industry is Korsch in?

Korsch's product category is Pharmaceutical Tablet Press Equipment. Its primary akta.pro industry code is IMAHAOAF, Filling & Dosing Machines (Liquid/Powder/Solid), with a secondary code of IMALAOAB, Filling & Dosing Equipment (Liquid, Powder, Aseptic).

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswirePiramal Pharma Solutions commémore le 20e anniversaire de son site de Morpeth en achetant une presse à comprimés Korsch X3Piramal Pharma Solutions' Morpeth site has commissioned a Korsch X3 tablet press to mark its 20th anniversary of pharmaceutical manufacturing operations. The X3 is custom-configured for handling highly potent active pharmaceutical ingredients (HPAPI) at Band 5 exposure levels, featuring dual turrets capable of producing tablets up to 25 mm, enclosed feeding and discharge systems, and advanced operator safety mechanisms. Peter DeYoung, CEO of Piramal Global Pharma, stated that the acquisition reinforces the site's ability to meet growing demand for complex, personalized therapies while expanding its commercial manufacturing capabilities.PR NewswirePiramal Pharma Solutions feiert das 20-jährige Jubiläum seines Standorts in Morpeth mit der Anschaffung einer Korsch X3-TablettenpressePiramal Pharma Solutions has installed a Korsch X3 high-safety tablet press at its Morpeth, UK facility, marking the site's 20th anniversary. The press is equipped with full Safety Level 5 containment and a DryCon containment kit, enabling closed manufacturing of highly potent drugs at clinical and commercial scale. This investment enables the facility to meet rising demand for complex therapies and accelerate delivery of life-saving treatments to patients.PR NewswirePiramal Pharma Solutions Commemorates 20th Anniversary at Morpeth Facility with Procurement of Korsch X3 Tablet PressPiramal Pharma Solutions has installed a Korsch X3 high containment tablet press at its integrated API and oral solid dose manufacturing site in Morpeth, UK, marking the facility's 20th anniversary of pharmaceutical operations. The new press is custom-configured for highly potent active pharmaceutical ingredients (HPAPIs) with specialized containment features, expanding the site's tablet manufacturing capabilities across clinical and commercial scales. The investment reinforces Morpeth's capacity to produce complex therapies including hormonals and personalized treatments, with the equipment already fully commissioned and in active use.PR NewswirePiramal Pharma Solutions Commemorates 20th Anniversary at Morpeth Facility with Procurement of Korsch X3 Tablet PressPiramal Pharma Solutions installed a Korsch X3 high containment tablet press at its Morpeth, UK facility, marking the site's 20th anniversary as an integrated API and oral solid development and manufacturing site. The press is custom-configured for highly potent active pharmaceutical ingredients (HPAPIs) with specialized containment features, expanding the site's tablet manufacturing capabilities to handle larger tablet sizes and a broader range of formulations at clinical and commercial scales. The CEO stated this acquisition strengthens their ability to serve patients in therapeutic areas requiring high potency materials such as hormonals.NewswirePiramal Pharma Solutions Commemorates 20th Anniversary at Morpeth Facility with Procurement of Korsch X3 Tablet PressPiramal Pharma Solutions installed a Korsch X3 high containment tablet press at its Morpeth, UK facility, marking the site's 20th anniversary. The press supports 25mm tablets and includes containment features for HPAPIs, expanding the site's manufacturing capabilities.Eqs-newsPiramal Pharma Solutions Commemorates 20th Anniversary at Morpeth Facility with Procurement of Korsch X3 Tablet PressPiramal Pharma Solutions installed a Korsch X3 high containment tablet press at its Morpeth, UK facility, marking the site's 20th anniversary of pharmaceutical manufacturing. The press features Band 5 containment technology and specialized equipment for handling highly potent active pharmaceutical ingredients at both clinical and commercial scales. This investment positions the Morpeth site to meet growing demand for complex, personalized therapies requiring high-potency drug manufacturing capabilities.PR NewswirePiramal Pharma Solutions augmente ses capacités de formulation avec l'ajout d'une nouvelle presse à comprimés bicouches Korsch XM-12 sur son site de Morpeth, au Royaume-Uni.Piramal Pharma Solutions has installed a new Korsch XM-12 bilayer tablet press at its Morpeth, United Kingdom facility to expand its formulation development and tablet production capabilities. The XM-12 press offers both monolayer and bilayer production capabilities with integrated technology for consistent output precision and reduced operator interaction. The company has implemented comprehensive training protocols with Korsch technicians to ensure proper equipment operation, validation, and qualification to meet industrial standards.PR NewswirePiramal Pharma Solutions Augments Formulation Capabilities with the Addition of New Korsch XM-12 Bilayer Tablet Press at its Morpeth, UK FacilityPiramal Pharma Solutions has installed a Korsch XM-12 bilayer tablet press at its drug product facility in Morpeth, UK, enhancing its formulation development and manufacturing capabilities for oral solids and hormonal products. The equipment enables high tablet output with precision and efficiency, featuring advanced containment technology for high potency APIs and rapid changeover capabilities with B and D changeout turrets. The company has implemented comprehensive training protocols alongside Korsch factory technicians to ensure proper handling and compliance with industry and Piramal's quality standards.